Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial: Genetic Mutations Associated With Ocular Diseases.
Yu M, Bouhenni R, Kurup SK, He W. Yu M, et al. Among authors: kurup sk. Front Cell Dev Biol. 2021 Dec 24;9:815522. doi: 10.3389/fcell.2021.815522. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 35004704 Free PMC article. No abstract available.
Ophthalmic Manifestations of Hodgkin Lymphoma: A Review.
Valenzuela J, Echegaray JJ, Dodds E, Kurup SK, Lowder C, Ondrejka SL, Singh AD. Valenzuela J, et al. Among authors: kurup sk. Ocul Oncol Pathol. 2021 Dec;7(6):381-389. doi: 10.1159/000519032. Epub 2021 Aug 17. Ocul Oncol Pathol. 2021. PMID: 35087814 Free PMC article. Review.
Reactivation of Acute Retinal Necrosis following SARS-CoV-2 Infection.
Gonzalez MP, Rios R, Pappaterra M, Hernandez M, Toledo A, Santos C, Emanuelli A, Kurup SK, Oliver AL. Gonzalez MP, et al. Among authors: kurup sk. Case Rep Ophthalmol Med. 2021 Jul 16;2021:7336488. doi: 10.1155/2021/7336488. eCollection 2021. Case Rep Ophthalmol Med. 2021. PMID: 34336325 Free PMC article.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.
Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.
66 results